Fulgent Genetics (FLGT) FCF Margin (2015 - 2026)

Fulgent Genetics has disclosed FCF Margin across 12 years of filings, most recently posting 32.34% for Q2 2026.

• In Q2 2026, FCF Margin rose 1289.0% year-over-year to 32.34%; the TTM figure through Jun 2026 stood at 43.07% (down 2329.0% YoY), while the FY2025 annual figure was 38.49%, down 3170.0% from the prior year.
• FCF Margin came in at 32.34% for Q2 2026 at Fulgent Genetics, down from 2.66% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 57.16% in Q1 2022 to a low of 20780.75% in Q4 2025.
• Average FCF Margin over 5 years is 1154.1%, with a median of 3.82% recorded in 2026.
• The largest YoY upside for FCF Margin was 5486 bps in 2025 against a maximum downside of 2080862 bps in 2025.
• Over 5 years, FCF Margin stood at 34.07% in 2022, then plunged by 51 bps to 16.77% in 2023, then jumped by 66 bps to 27.87% in 2024, then slumped by 74666 bps to 20780.75% in 2025, then soared by 100 bps to 32.34% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 32.34% in Q2 2026, 2.66% in Q1 2026, and 20780.75% in Q4 2025.